Stay updated on Pembrolizumab in Esophageal Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.

Latest updates to the Pembrolizumab in Esophageal Ca Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study’s recruitment status was updated to no longer look for participants, indicating enrollment has ended. The record now shows a revision to v3.6.0, replacing the previous v3.5.5 in the history.SummaryDifference0.1%

- Check15 days agoChange DetectedThe latest revision entry adds Revision: v3.5.5 and removes Revision: v3.5.4, indicating a small update to the page history.SummaryDifference0.0%

- Check37 days agoChange DetectedThe history section gained new content areas (IPDSharing, Study Design, Study Status, and Study Identification) on 2026-05-13, accompanied by a new revision entry (Revision: v3.5.4). This updates how the study record is structured and tracked over time.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page’s interface revision label was updated from v3.5.2 to v3.5.3, reflecting a site/platform version change without altering the underlying study history details.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Esophageal Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.